✦ LIBER ✦

A multicenter phase II study of pegylated liposomal doxorubicin and oxaliplatin in recurrent ovarian cancer

✍ Scribed by Francesco Recchia; Gaetano Saggio; Giovanna Amiconi; Anna Di Blasio; Alisia Cesta; Giampiero Candeloro; Gaspare Carta; Stefano Necozione; Giovanni Mantovani; Silvio Rea

Book ID: 113961056
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 235 KB
Volume: 106
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2007.03.015

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of pegylated liposomal do

Phase II study of pegylated liposomal doxorubicin and oxaliplatin in relapsed advanced ovarian cancer

✍ M.O. Nicoletto; C. Falci; D. Pianalto; G. Artioli; P. Azzoni; G. De Masi; E. Fer 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 128 KB

Association of pegylated liposomal doxor

Association of pegylated liposomal doxorubicin and ifosfamide in early recurrent ovarian cancer patients: A Multicenter Phase II Trial

✍ Florence Joly; Emmanuel Sevin; Alain Lortholary; Frank Priou; J.F. Paitel; Miche 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 299 KB

A phase II study of pegylated liposomal

A phase II study of pegylated liposomal doxorubicin oxaliplatin and cyclophosphamide as second-line treatment in relapsed ovarian carcinoma

✍ M.R. VALERIO; P. TAGLIAFERRI; F. RASPAGLIESI; F. FULFARO; G. BADALAMENTI; C. ARC 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB

A phase I study of irinotecan and pegyla

A phase I study of irinotecan and pegylated liposomal doxorubicin in recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 104 study)

✍ Shoji, Tadahiro; Takatori, Eriko; Kaido, Yoshitaka; Omi, Hideo; Yokoyama, Yoshih 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 201 KB

Phase 1/2 Study of Atrasentan Combined w

Phase 1/2 Study of Atrasentan Combined with Pegylated Liposomal Doxorubicin in Platinum-Resistant Recurrent Ovarian Cancer

✍ Witteveen, Petronella O.; van der Mijn, Koen J.C.; Los, Maartje; Kronemeijer, Ro 📂 Article 📅 2010 🏛 Neoplasia Press 🌐 English ⚖ 147 KB

Phase II study of the combination of peg

Phase II study of the combination of pegylated liposomal doxorubicin and topotecan in platinum-resistant ovarian cancer

✍ M. VERHAAR-LANGEREIS; A. KARAKUS; M. Van EIJKEREN; E. VOEST; E. WIT 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB